Correlation Between Singular Genomics and P3 Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Singular Genomics and P3 Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Genomics and P3 Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singular Genomics Systems and P3 Health Partners, you can compare the effects of market volatilities on Singular Genomics and P3 Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Genomics with a short position of P3 Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Genomics and P3 Health.

Diversification Opportunities for Singular Genomics and P3 Health

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Singular and PIII is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and P3 Health Partners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on P3 Health Partners and Singular Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Genomics Systems are associated (or correlated) with P3 Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of P3 Health Partners has no effect on the direction of Singular Genomics i.e., Singular Genomics and P3 Health go up and down completely randomly.

Pair Corralation between Singular Genomics and P3 Health

Given the investment horizon of 90 days Singular Genomics Systems is expected to generate 1.4 times more return on investment than P3 Health. However, Singular Genomics is 1.4 times more volatile than P3 Health Partners. It trades about 0.21 of its potential returns per unit of risk. P3 Health Partners is currently generating about -0.16 per unit of risk. If you would invest  1,332  in Singular Genomics Systems on August 29, 2024 and sell it today you would earn a total of  858.00  from holding Singular Genomics Systems or generate 64.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Singular Genomics Systems  vs.  P3 Health Partners

 Performance 
       Timeline  
Singular Genomics Systems 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.
P3 Health Partners 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days P3 Health Partners has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Singular Genomics and P3 Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Singular Genomics and P3 Health

The main advantage of trading using opposite Singular Genomics and P3 Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Genomics position performs unexpectedly, P3 Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in P3 Health will offset losses from the drop in P3 Health's long position.
The idea behind Singular Genomics Systems and P3 Health Partners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Managers
Screen money managers from public funds and ETFs managed around the world